Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ChIP-Seq, CPD-Seq and RNA-Seq in retinoblastoma 1 (RB1) knock out cells

ABSTRACT: ChIP-Seq, CPD-Seq and RNA-Seq in retinoblastoma 1 (RB1) knock out cells

PROVIDER: PRJNA723856 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Similar Datasets

RNA-Seq in retinoblastoma 1 (RB1) knock out IMR-90 cells

Project description:Total RNA-seq with rRNA depletion in retinoblastoma protein 1 knockout (RB1 KO) IMR-90

2021-12-29 | GSE173127 | GEO

UV-induced DNA lesion mapping in retinoblastoma 1 (RB1) knock out cells

Project description:In this study, we generated a human genome-wide map of DNA lesions induced by ultraviolet (UV) radiation in retinoblastoma knockout (RB1 KO) cells. Interestingly, we observed increased carcinogen susceptibility in closed HI-C domainS, pericentric and subtelomeric regions in RB1 KO. We also observed increased susceptibility at cancer driver loci such as TERT and TPTE. These loci are highly mutated in melanoma. Finally, we proposed that loss of tumor suppressor function can alter carcinogen susceptibility, and subsequently the mutation frequency of the genome.

2021-12-29 | GSE173126 | GEO

RNA-Seq in retinoblastoma 1 (RB1) knock out IMR-90 cells

Project description:RNA-Seq in retinoblastoma 1 (RB1) knock out IMR-90 cells

| PRJNA723859 | ENA

H3K9me3 and H3K27me3 ChIP-Seq in retinoblastoma 1 (RB1) knock out cells

Project description:H3K9me3 and H3K27me3 ChIP-Seq in retinoblastoma 1 (RB1) knock out cells

| PRJNA723852 | ENA

H3K9me3 and H3K27me3 ChIP-Seq in retinoblastoma 1 (RB1) knock out cells

Project description:Comparative analysis of H3K9me3 and H3K27me3 in RB1 KO and wild type IMR-90 cells

2021-12-29 | GSE173125 | GEO

ChIP-Seq, CPD-Seq and RNA-Seq in retinoblastoma 1 (RB1) knock out cells

Project description:This SuperSeries is composed of the SubSeries listed below.

2021-12-29 | GSE173128 | GEO

UV-induced DNA lesion mapping in retinoblastoma 1 (RB1) knock out cells

Project description:UV-induced DNA lesion mapping in retinoblastoma 1 (RB1) knock out cells

| PRJNA723855 | ENA

Enhanced Innate Response In RB1 deficient Microglia Derived From Retinoblastoma Patient

Project description:Retinoblastoma (Rb), the most prevalent intraocular malignant tumor in children with global survival rate less than 30%, is mainly caused by the deficiency of the tumor suppressor RB1. A line of evidence have shown that local inflammation and immune escape play important roles in the occurrence of Rb, however the underlying mechanism remains unclear. We hypothesize that the unique neuroimmune cell type, retinal microglia, has a vital role in the Rb pathogenesis. In this study, we differentiated microglia cells (iMGs) from established induced pluripotent stem cells (iPSCs) derived from a retinoblastoma patient with the defined RB1 mutations. We investigated the function of RB1 in innate immune response of microglia and found that the expression of interleukins and chemokines, especially interleukin 6 and TNF-α, were highly upregulated in LPS-stimulated RB1 deficient iMGs, which enhanced innate immune responses and created a pro-inflammation environment. These findings demonstrated that RB1 is indispensable to maintain microglia function in innate immunity and its deficiency leads to enhanced inflammation responses, which may accelerate tumor growth and malignancy. This study provides new insights for pathological mechanism and immunotherapeutic target of retinoblastoma.

2022-12-31 | GSE212248 | GEO

Silencing of the Long Noncoding RNA MYCNOS1 Suppresses Activity of MYCN-Amplified Retinoblastoma Without RB1 Mutation

Project description:MYCNOS (MYCN opposite strand) is co-amplified with MYCN in pediatric cancers including retinoblastoma. MYCNOS encodes several RNA variants whose functions have not been elucidated in retinoblastoma. Here, we attempted to decipher the role of MYCNOS variant 1 (MYCNOS1) on the activity of MYCN-amplified retinoblastoma. We observed that MYCNOS1 supports progression of retinoblastoma. Inhibition of MYCNOS1 expression may be needed to suppress MYCN activity when treating MYCN-amplified cancers without RB1 mutation.

2020-12-15 | GSE161449 | GEO

RB1 loss triggers dependence on ESRRG in retinoblastoma

Project description:Retinoblastoma (Rb) is a deadly childhood eye cancer that is classically initiated by inactivation of the RB1 tumor suppressor. Clinical management continues to rely on nonspecific chemotherapeutic agents that are associated with treatment resistance and toxicity. Here, we analyzed 103 whole exomes, 16 whole transcriptomes, 5 single-cell transcriptomes, and 4 whole genomes from primary Rb tumors to identify novel Rb dependencies. Several recurrent genomic aberrations implicate estrogen-related receptor gamma (ESRRG) in Rb pathogenesis. RB1 directly interacts with and inhibits ESRRG, and RB1 loss uncouples ESRRG from negative regulation. ESRRG regulates genes involved in retinogenesis and oxygen metabolism in Rb cells. ESRRG is preferentially expressed in hypoxic Rb cells in vivo. Depletion or inhibition of ESRRG causes marked Rb cell death which is exacerbated in hypoxia. These findings reveal a novel dependency of Rb cells on ESRRG, and they implicate ESRRG as a potential therapeutic vulnerability in Rb.

2022-08-24 | GSE196420 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data